11-108301698-C-T
Variant summary
Our verdict is Pathogenic. The variant received 4 ACMG points: 4P and 0B. PP3PM3PS3_Supporting
This summary comes from the ClinGen Evidence Repository: The c.5228C>T variant in ATM is a missense variant predicted to cause substitution of threonine by isoleucine at amino acid 1743 (p.Thr1743Ile). This variant has been detected in numerous unrelated individuals with Ataxia-Telangiectasia (PMIDs: 19147735, 21792198, 26896183, 31921190). The highest population minor allele frequency in gnomAD v4.1.0 is 0.00008476 in the European (non-Finnish) population (PM2_Supporting, BS1, and BA1 are not met). Western blotting in ATM null cells transfected with cDNA carrying this variant showed a reduction in phosphorylation of ATM downstream targets as compared to wild-type controls, indicating that this variant impacts protein function (PMID:19431188). The computational predictor REVEL gives a score of 0.835 which is above the threshold of 0.7333, evidence that correlates with impact to ATM function. In summary, this variant meets the criteria to be classified as pathogenic for autosomal dominant ATM-related cancer predisposition and autosomal recessive Ataxia-Telangiectasia based on the ACMG/AMP criteria applied as specified by the HBOP VCEP. (PM3_VeryStrong, PS3_Supporting, PP3). LINK:https://erepo.genome.network/evrepo/ui/classification/CA286882/MONDO:0700270/020
Frequency
Consequence
NM_000051.4 missense
Scores
Clinical Significance
Conservation
Publications
- ATM-related cancer predispositionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- ataxia telangiectasiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Laboratory for Molecular Medicine
- prostate cancerInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- sarcomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- gastric carcinomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATM | MANE Select | c.5228C>T | p.Thr1743Ile | missense | Exon 35 of 63 | ENSP00000501606.1 | Q13315 | ||
| ATM | TSL:1 | c.5228C>T | p.Thr1743Ile | missense | Exon 36 of 64 | ENSP00000388058.2 | Q13315 | ||
| ATM | TSL:1 | n.*292C>T | non_coding_transcript_exon | Exon 33 of 61 | ENSP00000435747.2 | E9PIN0 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152060Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251178 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000698 AC: 102AN: 1461478Hom.: 0 Cov.: 31 AF XY: 0.0000660 AC XY: 48AN XY: 727058 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152060Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74278 show subpopulations
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at